The DOI matches its Crossref record; 58 of the 59 references it cites were found in a registry or an index.
Abnormalities of mitochondrial enzymes in Alzheimer disease
Abstract
Abundant evidence, including critical information gathered by Prof. Siegfried Hoyer and his colleagues, indicates that abnormalities of cerebral metabolism are common in neurodegenerative diseases, including Alzheimer's Disease (AD). Alterations in mitochondrial enzymes likely underlie these deficits. Replicable reductions in AD brain occur in the pyruvate dehydrogenase complex (the link of glycolysis to the Kreb's cycle), the alpha-ketoglutarate dehydrogenase complex (KGDHC; the link of Kreb's cycle to glutamate metabolism) and cytochrome oxidase (the link of the Kreb's cycle to oxygen utilization). Available evidence suggests that deficiencies in KGDHC may be genetic in some cases, whereas evidence that the other two enzyme systems have a genetic component is lacking. Additional results indicate that the reductions can also be secondary to other causes including oxidative stress. A variety of data suggest that the mitochondrial insufficiencies contribute significantly to the pathophysiology of AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Relative to control brains, in AD brains several mitochondrial enzymes have reduced Vmax activities. Examples include two dehydrogenase enzymes, pyruvate dehydrogenase and ketoglutarate dehydrogenase [124].”
From Brain aging, Alzheimer's disease, and mitochondria (2011) · cites this paper as [124]
Citations
Cites
1 retracted
Davis, R. E., Miller, S., Herrnstadt, C., Ghosh, S. S., Fahy, E., Shinobu, L. A., Galasko, D., Thal, L. J., Beal, M. F., Howell, N., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4526 · Cited by 341
RetractedOxidative stress hypothesis in Alzheimer’s disease
Markesbery, W. R. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00629-6 · Cited by 2,383
Reiman, E. M., Caselli, R. J., Yun, L. S., Chen, K., Bandy, D., Minoshima, S., Thibodeau, S. N., & Osborne, D. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603213341202 · Cited by 1,366
Small, G. W. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03520360056039 · Cited by 604
Cytochrome oxidase deficiency in Alzheimer’s disease
Parker, W. D., Filley, C. M., & Parks, J. K. (1990) · Neurology · doi:10.1212/wnl.40.8.1302 · Cited by 598 · cited 2×
“Deficiency of COX activity in platelets has been reported (Parker et al., 1990) and disputed (VanZuylen et al., 1992).”
BackgroundBrain cytochrome oxidase in Alzheimer's disease
Kish, S. J., Bergeron, C., Rajput, A., Dozic, S., Mastrogiacomo, F., Chang, L., Wilson, J. M., DiStefano, L. M., & Nobrega, J. N. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb09439.x · Cited by 537
Bolaños, J. P., Almeida, Á., Stewart, V. C., Peuchen, S., Land, J. M., Clark, J. B., & Heales, S. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68062227.x · Cited by 519
Goodman, Y., & Mattson, M. P. (1994) · Experimental Neurology · doi:10.1006/exnr.1994.1107 · Cited by 449
Cruts, M., van Duijn, C. M., Backhovens, H., den Broeck, M. V., Wehnert, A., Serneels, S., Sherrington, R., Hutton, M., Hardy, J., George‐Hyslop, P. S., et al. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.1.43 · Cited by 432
Gibson, G. E., Sheu, K. ‐. R., Blass, J. P., Baker, A., Carlson, K., Harding, B. N., & Perrino, P. (1988) · Archives of Neurology · doi:10.1001/archneur.1988.00520320022009 · Cited by 425
Decreased pyruvate dehydrogenase complex activity in Huntington and Alzheimer brain
Sorbi, S., Bird, E. D., & Blass, J. P. (1983) · Annals of Neurology · doi:10.1002/ana.410130116 · Cited by 400
Inhibition of Amyloid β Protein Aggregation and Neurotoxicity by Rifampicin
Tomiyama, T., Shoji, A., Kataoka, K.-I., Suwa, Y., Asano, S., Kaneko, H., & Endo, N. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.12.6839 · Cited by 295
Yates, C. M., Butterworth, J., Tennant, M. C., & Gordon, A. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb04948.x · Cited by 263
Cybrids in Alzheimer's disease: A cellular model of the disease?
Swerdlow, R. H., & Parker, D. W. (1998) · Neurology · doi:10.1212/wnl.51.1.326-a · Cited by 260
Sheehan, J. P., Swerdlow, R. H., Miller, S. W., Davis, R. E., Parks, J. K., Parker, W. D., & Tuttle, J. B. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-12-04612.1997 · Cited by 249
Physiology and pathology of tau protein kinases in relation to Alzheimer's disease.
Imahori, K., & Uchida, T. (1997) · PubMed · Cited by 236
Perry, E. K., Perry, R. H., Tomlinson, B. E., Blessed, G., & Gibson, P. H. (1980) · Neuroscience Letters · doi:10.1016/0304-3940(80)90220-7 · Cited by 236
Peterson, C., & Goldman, J. E. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.8.2758 · Cited by 221
Wallace, D. C., Stugard, C., Murdock, D. G., Schurr, T. G., & Brown, M. D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14900 · Cited by 219
Glucose enhancement of memory in patients with probable senile dementia of the Alzheimer's type.
Manning, C., Ragozzino, M., & Gold, P. E. (1993) · Neurobiology of Aging · doi:10.1016/0197-4580(93)90034-9 · Cited by 214
Goodman, Y., Steiner, M. R., Steiner, S. M., & Mattson, M. P. (1994) · Brain Research · doi:10.1016/0006-8993(94)91586-5 · Cited by 202
Mitochondrial function in brain tissue in primary degenerative dementia
Sims, N. R., Finegan, J. M., Blass, J. P., Bowen, D. M., & Neary, D. (1987) · Brain Research · doi:10.1016/0006-8993(87)91553-8 · Cited by 182
Thiamine-dependent enzyme changes in temporal cortex of patients with Alzheimer's disease
Butterworth, R. F., & Besnard, A.-M. (1990) · Metabolic Brain Disease · doi:10.1007/bf00997071 · Cited by 164
Cytochrome C Oxidase in Alzheimer's Disease Brain: Purification and Characterization
Parker, W. D., & Parks, J. K. (1995) · Neurology · doi:10.1212/wnl.45.3.482 · Cited by 142
Hirano, M., Shtilbans, A., Mayeux, R. P., Davidson, M. M., DiMauro, S., Knowles, J. A., & Schon, E. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14894 · Cited by 133
Sims, N. R., Bowen, D. M., & DAVISON, A. N. (1981) · Biochemical Journal · doi:10.1042/bj1960867 · Cited by 132
Brain protein and α‐ketoglutarate dehydrogenase complex activity in alzheimer‐s disease
Mastrogiacomo, F., LINDSAY, J. G., Bettendorff, L., Rice, J., & Kish, S. J. (1996) · Annals of Neurology · doi:10.1002/ana.410390508 · Cited by 132
Wong-Riley, M., Antuono, P., Ho, K.-C., Egan, R., Hevner, R., Liebl, W., Huang, Z., Rachel, R., & Jones, J. L. (1997) · Vision Research · doi:10.1016/s0042-6989(96)00210-6 · Cited by 127
Sims, N. R., Bowen, D. M., Neary, D., & DAVISON, A. N. (1983) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1983.tb00829.x · Cited by 126
Farrer, L. A. (1997) · JAMA · doi:10.1001/jama.1997.03550160069041 · Cited by 124
Altered metabolic properties of cultured skin fibroblasts in Alzheimer's disease
Sims, N. R., Finegan, J. M., & Blass, J. P. (1987) · Annals of Neurology · doi:10.1002/ana.410210507 · Cited by 123
Evidence for Physiological Down-regulation of Brain Oxidative Phosphorylation in Alzheimer's Disease
Chandrasekaran, K., Hatanpaa, K. J., Brady, D. R., & Rapoport, S. I. (1996) · Experimental Neurology · doi:10.1006/exnr.1996.0180 · Cited by 117
Sheu, K. R., Cooper, A. J. L., Koike, K., Koike, M., LINDSAY, J. G., & Blass, J. P. (1994) · Annals of Neurology · doi:10.1002/ana.410350311 · Cited by 108
Simonian, N. A., & Hyman, B. T. (1994) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199409000-00010 · Cited by 108
Schoonen, W. G. E. J., Wanamarta, A. H., Moorsel, J. M. V. D. K., Jakobs, C., & Joenje, H. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38565-5 · Cited by 99
Oxidative metabolism deficiencies in brains of patients with Alzheimer's disease
Hoyer, S. (1996) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1996.tb05868.x · Cited by 88
Kish, S. J. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48473.x · Cited by 83
Defects at Center P Underlie Diabetes-Associated Mitochondrial Dysfunction
Kristal, B. S., Jackson, C. T., Chung, H., Matsuda, M., Nguyen, H. D., & Yu, B. P. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00428-5 · Cited by 82
Haycock, J. W., Jones, P., Harris, J. B., & Mantle, D. (1996) · Acta Neuropathologica · doi:10.1007/s004010050527 · Cited by 77
Westergaard, N., Sonnewald, U., Petersen, S. B., & Schousboe, A. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(94)11216-6 · Cited by 67
Altered regulation of brain glucose metabolism as a cause of neurodegenerative disorders?
Blum-Degen, D., Frölich, L., Hoyer, S., & Riederer, P. F. (1995) · PubMed · Cited by 55
Mitochondrial DNA Mutations in Alzheimer's Disease
Hutchin, T. P., Heath, P. R., Pearson, R. C. A., & Sinclair, A. J. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7793 · Cited by 51
The genetics of Alzheimer's disease
Rubinsztein, D. C. (1997) · Progress in Neurobiology · doi:10.1016/s0301-0082(97)00014-2 · Cited by 48
Scoonen, W. G. E. J., Wanamarta, A. H., Moorsel, J. M. V. D. K., Jakobs, C., & Joejne, H. (1990) · Mutation Research/DNAging · doi:10.1016/0921-8734(90)90023-k · Cited by 46
Metabolic alterations common to neural and non‐neural cells in alzheimer's disease
Blass, J. P. (1993) · Hippocampus · doi:10.1002/hipo.1993.4500030708 · Cited by 45
Models of Alzheimer’s disease: cellular and molecular aspects
Hoyer, S. (1997) · Springer eBooks · doi:10.1007/978-3-7091-6844-8_2 · Cited by 43
Nakano, K., Takase, C., Sakamoto, T., Nakagawa, S., Inazawa, J., Ohta, S., & Matuda, S. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.tb20010.x · Cited by 35
Localization of the human dihydrolipoamide dehydrogenase gene (DLD) to 7q31→q32
Scherer, S. W., Otulakowski, G., Robinson, B. H., & Tsui, L.-C. (2008) · Cytogenetics and Cell Genetics · doi:10.1159/000133081 · Cited by 32
Molina, J. A., de Bustos, F., Jiménez‐Jiménez, F. J., Benito‐León, J., Gasalla, T., Pareja, M. O., Vela, L., Bermejo, F., Martín, M. A., Campos, Y., et al. (1997) · Neurology · doi:10.1212/wnl.48.3.636 · Cited by 32
Tirmenstein, M. A., Mathias, P. I., SNAWDER, J. E., Wey, H. E., & Toraason, M. A. (1997) · Toxicology · doi:10.1016/s0300-483x(97)03628-7 · Cited by 31
Kumar, U., Dunlop, D. M., & Richardson, J. S. (1994) · International Journal of Neuroscience · doi:10.3109/00207459408986079 · Cited by 30
Alzheimer's disease and DLST genotype
Nakano, K., Ohta, S., Nishimaki, K., Miki, T., & Matuda, S. (1997) · The Lancet · doi:10.1016/s0140-6736(05)65139-2 · Cited by 29
Free Radicals in the Neurotoxic Actions of β‐Amyloida
Richardson, J. S., Zhou, Y., & Kumar, U. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb34446.x · Cited by 25
Szabo, P., Cai, X., Ali, G., & Blass, J. P. (1994) · Genomics · doi:10.1006/geno.1994.1178 · Cited by 20
Schoonen, W. G. E. J., Wanamarta, A. H., Moorsel, J. M. V. D. K., Jakobs, C., & Joenje, H. (1991) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(91)90004-m · Cited by 15
Cerebral Metabolic Impairments
Blass, J. P. (1996) · Informa Healthcare eBooks · doi:10.1201/9781420048407.ch15 · Cited by 13
Causes and Consequences of Neuronal Energy Deficit in Sporadic Alzheimer's Disease
Bauer, J., Plaschke, K., Martin, E., Bardenheuer, H. J., & Hoyer, S. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48487.x · Cited by 8
Increased activity of surviving locus ceruleus neurons in Alzheimer's disease
Moser (1999) · Pure Amsterdam UMC · doi:10.1002/1531-8249(199901)45:1
Flagged first, then by citations
1 of the 59 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Oxidative stress and mitochondrial dysfunction in Alzheimer’s disease
Wang, X., Wang, W., Li, L., Perry, G., Lee, H.-G., & Zhu, X. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.10.015 · Cited by 1,357
Reddy, P. H., & Beal, M. F. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.12.002 · Cited by 975
Mitochondrial Dysfunction in Neurodegenerative Diseases
Johri, A., & Beal, M. F. (2012) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.192138 · Cited by 806
History and progress of hypotheses and clinical trials for Alzheimer’s disease
Liu, P.-P., Xie, Y., Meng, X.-Y., & Kang, J.-S. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0063-8 · Cited by 723
Alzheimer's Disease: From Pathology to Therapeutic Approaches
Jakob‐Roetne, R., & Jacobsen, H. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200802808 · Cited by 626
Metadata
- Authors
- Gibson, G. E., Sheu, K.-F. R., & Blass, J. P.
- Affiliations
- Cornell University (US)
- ORCID
- Gibson, G. E.
- Venue
- Journal of Neural Transmission
- Published
- 1998-11-04
- Volume
- 105
- Issue
- 8-9
- Pages
- 855-870
- ISSN
- 0300-9564 (ISSN-L)
- 1435-1463
- OpenAlex
- W1989462226
- Cited by
- 345
- References
- 59
- Citations by year
- 2026: 6 · 2025: 7 · 2024: 7 · 2023: 14 · 2022: 14 · 2021: 12 · 2020: 20 · 2019: 12 · 2018: 11 · 2017: 15 · 2016: 23 · 2015: 19 · 2014: 7 · 2013: 14 · 2012: 12
- FWCI
- 4.29
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Neural Transmission (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r35ag009014-07)
- National Institute on Aging (AG11921, AG 09014, R01AG014600, R01AG011921, AG-14600)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Biochemical Acid Research Studies
- Keywords
- Alzheimer's disease, mitochondrial enzymes, pyruvate dehydrogenase complex, alpha-ketoglutarate dehydrogenase complex, cytochrome c oxidase, brain metabolism, neurodegeneration, oxidative stress, TCA cycle, glutamate metabolism, genetic deficiency
- MeSH terms
- Alzheimer Disease, Electron Transport Complex IV, Humans, Ketoglutarate Dehydrogenase Complex, Mitochondria, Pyruvate Dehydrogenase Complex, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review